Skip to content

INHIBRX BIOSCIENCES, INC.

INBX

CIK 0002007919

← back to feed
Revenue (TTM)
$1.3M
+550.0% YoY Q1 May 2026
Net Income (TTM)
−$140.66M
−108.3% YoY Q1 May 2026
EPS Diluted (TTM)
−$9.08
−108.0% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-10,386.8%
Q1 May 2026
Net Margin
-10,820.2%
Q1 May 2026
Free Cash Flow (TTM)
−$129.83M
Q1 May 2026
Cash
$161.66M
Q1 May 2026
Total Debt
$174.99M
Q1 May 2026
Shares Outstanding
14.67M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings